Fox Chase Cancer Center News

Fox Chase Cancer Center to Improve Breast Cancer Detection

PHILADELPHIA, (July 5, 2017) – Fox Chase Cancer Center announced the addition of the Discovery™ NM750b Molecular Breast Imaging (MBI) system as a complementary diagnostic tool to detect breast cancer after a questionable mammogram. MBI is now available to help physicians in the Philadelphia area detect early stage cancers even in dense breast tissue. 

VIEW STORY

Researchers Identify Several New Genetic Mutations that Increase Risk of Breast and Ovarian Cancer

PHILADELPHIA (June 27, 2017) – Analyzing a panel of 25 genes, researchers found mutations in genes associated with increased risk of breast or ovarian cancer in approximately seven percent of women tested through a large commercial laboratory. Depending on the gene, they found increased risk between two- and six-fold for breast cancer and two- and forty-fold for ovarian cancer.

VIEW STORY

Remembering W. Thomas London, MD

PHILADELPHIA (June 6, 2017) - It is with great respect that we remember and pay tribute to an admired colleague and friend, a luminary in his field, and a noted figure within Fox Chase Cancer Center’s legacy. We join you in mourning the loss of W. Thomas London, MD, Professor Emeritus, on Saturday, June 3, following an apparent heart attack. He was 85 years old.

VIEW STORY

Breast Cancer Drug Found to be Ineffective in Treating Squamous Non-Small Cell Lung Cancer

PHILADELPHIA (June 2, 2017) - Martin J. Edelman, MD, FACP, chair of Hematology/Oncology at Fox Chase Cancer Center, presented the results of a clinical study testing palbociclib at the American Society of Clinical Oncology annual meeting in Chicago. Of the 32 patients evaluated, only two responded to the drug, showing it to be ineffective on its own for patients with squamous NSCLC.

VIEW STORY